FDA's Executive Responsibility Policy Could Sweep In Board Members
Executive Summary
Add board members to the list of company executives who could be personally affected by FDA's plans to focus on responsible individuals in the corporations it takes to task as part of its enforcement mission.
You may also be interested in...
Rx Fraud Investigations Could Get Boost From Health Care Reform's Transparency Requirements
Former DoJ prosecutor Michael Loucks says there is pressure from Congress to exclude companies from government programs, particularly if they have prior settlements with the government.
Prosecuting "Responsible" Execs: FDA Brandishes Powerful Legal Weapon
Company executives increasingly could be caught on the wrong side of virtually unbeatable government criminal prosecutions if FDA follows up on recently announced enforcement plans, industry attorneys warn
FDA Ad Enforcement Steams On; Are “Days Of Pushing The Envelope” Over?
FDA's aggressive enforcement of its advertising standards, and the agency's new enforcement allies, mean that industry may now have more to fear from a citation letter